Advertisement

Topics

Search Results for "Http Dx Doi Org 10 1002 Adma 201104290"

10:08 EDT 30th June 2016 | BioPortfolio

Matching Channels

Freiberg Infraction

Freiberg's disease is an osteochondrosis of the metatarsal head, most commonly occurring in young athletes older than 12 years who perform on their toes in either sprinting or jumping activities...

Pediculosis - louse (lice) treatment

   To view our most recent articles on Lice Treatment please go to: http://www.bioportfolio.com/news/article/987636/Pediculosis-Louse-Lice-Treatment.html    

Pediculosis - louse (lice) infestation

   To view our most recent article on Lice Infestation please go to: http://www.bioportfolio.com/news/article/987568/Pediculosis-Louse-Lice-Infestation.html 

Pediculosis - louse (lice) diagnosis

   To view our most recent articals on Lice Diagnosis please view: http://www.bioportfolio.com/news/article/987588/Pediculosis-Louse-Lice-Diagnosis.html

G-protein-coupled receptors (GPCRs)

GPCRs are a large family of cell surface receptors that respond to a variety of external signals. Binding of a signaling molecule to a GPCR results in G protein activation, which in turn triggers th...

Matching News

ADMA nets $11.6mm via FOPO

ADMA Biologics Inc. (infectious disease therapies) netted $11.6mm through the follow-on public offering of 1.9mm common shares at $6.50 each.

ADMA nets $13.3mm via FOPO

ADMA Biologics Inc. (infectious disease therapies) netted $13.3mm through the follow-on public offering of 2.2mm common shares (including the overallotment) at $6.50 each.

BRIEF-Adma biologics reports FY loss per share of $1.73

* Adma biologics reports year end 2015 financial results, accomplishments and upcoming milestones

BRIEF-ADMA Biologics prices offering of 1.89 mln common shares at $6.50/shr

* ADMA biologics announces pricing of public offering of common stock

BRIEF-ADMA Biologics announces proposed public offering of common stock

* Adma Biologics announces proposed public offering of common stock Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

ADMA financial update

ADMA completes follow-on

ADMA Biologics Reports First Quarter 2016 Results

RAMSEY, N.J., May 13, 2016 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasm...

Matching PubMed Articles

Effect of ADMA levels on severity of erectile dysfunction in chronic kidney disease and other risk factors.

Hormonal, neurogenic, vasculogenic, and psychogenic impairments, as well as endothelial dysfunction may play a role in erectile dysfunction (ED) in patients with chronic kidney disease (CKD). Asymmetr...

Endogenous Asymmetric Dimethylarginine Pathway in High Altitude Adapted Yaks.

Hypoxia-induced and high altitude pulmonary hypertension are a major problem in the mountain areas of the world. The asymmetric methylarginines (ADMA) inhibit nitric oxide (NO) synthesis by competing ...

Does the ADMA/DDAH/NO pathway modulate early regression of left ventricular hypertrophy with esmolol?

Hypertensive left ventricular hypertrophy (LVH) is a maladaptive response to chronic pressure overload and a strong independent risk factor for cardiovascular disease. Regression of LVH is associated ...

High Levels of Methylarginines Were Associated with Increased Mortality in Patients with Severe Sepsis.

Nitric oxide (NO) likely plays a pivotal role in the pathogenesis of sepsis. Arginine is a substrate for NO, whereas the methylated arginines - asymmetric dimethylarginine (ADMA) and symmetric dimethy...

L-Arginine derivatives are associated with the hyperthyroid state in the general population.

Background Arginine (ARG) derivatives and thyroid function independently influence atherosclerotic processes. Since thyroid hormones may mediate the association between ARG derivatives and atheroscler...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement